Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Research in Alzheimer disease provides new insights
June 17th, 2005
Reports from the United States and Germany highlight recent research on Alzheimer disease. Study 1: According to recently published research from the United States, altered kinase expression accompanies disease progression in Alzheimer disease (AD). "AD is characterized by progressive decline in memory and other cognitive domains, accompanied by early loss of presynaptic terminals, amyloid-bearing neuritic plaques and neurofibrillary tangles containing hyperphosphorylated tau. The mechanisms leading to neurodegeneration are not completely understood, however, recent evidence suggests that alterations in p59Fyn kinase, an Src family...
Source: Drug Week (2005-06-17)
|
